Qiagen NV (NYSE: QGEN) has reported E.P.S. of $0.36 for its first fiscal quarter (ending March 31) versus $0.37 for the same period a year ago — a decline of -3%. This performance was $-0.11 short of the consensus estimate of $0.47. E.P.S. were $1.51 for the latest four quarters through March 31 versus $1.54 for the same period a year ago — a decline of -2%.
Recent Price Action
Qiagen NV (NYSE: QGEN) stock closed at $42.30 on 4/29/24 after an increase of 1.6%. Moreover, this advance was accompanied by exceptionally high trading volume at 270% of normal. The stock has risen 5.7% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, QGEN is expected to continue to be an important Value Builder.
Qiagen has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Qiagen has a slightly negative Appreciation Score of 39 and a slightly negative Power Rating of 38, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment